Global iPSCs Manufacturing Services Market

Report ID : 1223 | Published : 2022-11-23 | Pages: 180 | Format:

Induced Pluripotent Stem Cells (iPSC) are originated from skin or blood cells. iPSCs are cells that are reprogrammed from somatic cells using different transcription factors. These cells are pluripotent, have the potential for self-renewal, and can differentiate into any of the 220+ human cell types. iPSC has certain advantages over other stem cell types in regenerative medicine and wound healing models. iPSCs are used to produce patient-specific cells, which can be transplanted to the site of injury or tissue degeneration due to various disease conditions. iPS cells have the potential to become embryos if exposed to suitable conditions. Some important characteristics of iPSC are abundant somatic cells of the donor that can be used. Issues of histocompatibility with donor/recipient transplants can be avoided. Very useful for drug development and developmental studies.

Market growth factors are increasing research on personalized or precise medicine and extended applications in regenerative treatments and therapies due to the high therapeutic potential of iPS cells. Uprising trials and research on diseases like Parkinson's disease, Anemia, and cardiac syndromes will contribute to iPSC production. In the manufacturing of iPS cells, the use of an automated platform will boost the market with cost reduction and increased output. In Apr 2022, Ncardia launched a new business, Cellistic™, to focus Ncardia's induced pluripotent stem cell (iPSC) expertise on cell therapy development and manufacturing.   Affordable cost for cell therapy and demonstration of these therapies' safety and efficacy are market restraining factors. Also, methods for ensuring reproducibility and maintenance, as differentiated tissues are uncertain, are expected to hamper the market growth. The standard technique to create iPS cells uses viruses to transfer the reprogramming genes into the skin cells, which is one of iPS cells' cons.

Tumorigenicity, immune rejection, phenotypic heterogeneity of therapeutic cell products and genetic instability are prime challenges in stem cell research that will impact the production of iPS Cells.

iPSCs manufacturing services market is segmented into two main fragments. The first segmentation is by application, including Research Products, Drug Development & Discovery, Cellular Therapy, Toxicology Screening, Personalized Medicine, Disease Modelling, Stem Cell Banking, and Emerging Applications. The last segmentation is by end-user, which comprises Pharmaceutical & Biotechnology Companies, Academic institutes, Research Laboratories & CROs, Hospitals & Surgical Centres, Cell & Tissue Banks, Other End Users. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, & the Middle East and Africa.

North America is likely to witness rapid growth in the forecast period, followed by Europe due to fast research on cardiac diseases, neuropathies and personalized medicine production. Also, significant funding for development in iPSC manufacturing will be responsible for the growth.

Significant market key players are I Peace Inc., Lonza Group AG, Axol Bioscience Ltd., FUJIFILM Cellular Dynamics, Inc., Pluristyx, Inc., Ncardia, Cynata Therapeutics Limited, Evotec SE, Celogics Inc, Catalent, Inc, CCRM, Applied StemCell Inc. (ASC), RoslinCT, Takara Bio Inc, Thermo Fisher Scientific, Inc, Other Prominent Players

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global IPSCs Manufacturing Services Market Snapshot

Chapter 4. Global IPSCs Manufacturing Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 2: By End-Users Estimates & Trend Analysis

5.1. By End-Users & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

5.2.1. Pharmaceutical & Biotechnology Companies

5.2.2. Academic institutes, Research Laboratories & CROs

5.2.3. Hospitals & Surgical Centres

5.2.4. Cell & Tissue Banks

5.2.5. Other End Users

Chapter 6. Market Segmentation 4: By Applications Estimates & Trend Analysis

6.1. By Applications & Market Share, 2020& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Applications:

6.2.1. Research Products

6.2.2. Drug Development & Discovery

6.2.3. Cellular Therapy

6.2.4. Toxicology Screening

6.2.5. Personalized Medicine

6.2.6. Disease Modelling

6.2.7. Stem Cell Banking

6.2.8. Emerging Applications

Chapter 7. IPSCs Manufacturing Services Market Segmentation 5: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts By End-Users, 2019-2030

7.1.2. North America IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapy, 2019-2030

7.1.3. North America IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2019-2030

7.1.4. North America IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2019-2030

7.2. Europe

7.2.1. Europe IPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2019-2030

7.2.2. Europe IPSCs Manufacturing Services Market revenue (US$ Million) By Therapy, 2019-2030

7.2.3. Europe IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2019-2030

7.2.4. Europe IPSCs Manufacturing Services Market revenue (US$ Million) by country, 2019-2030

7.3. Asia Pacific

7.3.1. Asia Pacific IPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2019-2030

7.3.2. Asia Pacific IPSCs Manufacturing Services Market revenue (US$ Million) By Therapy, 2019-2030

7.3.3. Asia Pacific IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2019-2030

7.3.4. Asia Pacific IPSCs Manufacturing Services Market revenue (US$ Million) by country, 2019-2030

7.4. Latin America

7.4.1. Latin America IPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2019-2030

7.4.2. Latin America IPSCs Manufacturing Services Market revenue (US$ Million) By Therapy, 2019-2030

7.4.3. Latin America IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2019-2030

7.4.4. Latin America IPSCs Manufacturing Services Market revenue (US$ Million) by country, 2019-2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa IPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2019-2030

7.5.2. Middle East & Africa IPSCs Manufacturing Services Market revenue (US$ Million) By Therapy, 2019-2030

7.5.3. Middle East & Africa IPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2019-2030

7.5.4. Middle East & Africa IPSCs Manufacturing Services Market revenue (US$ Million) by country, 2019-2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. I Peace Inc.

8.2.2. Lonza Group AG

8.2.3. Axol Bioscience Ltd.

8.2.4. FUJIFILM Cellular Dynamics, Inc.

8.2.5. Ncardia

8.2.6. Cynata Therapeutics Limited

8.2.7. Evotec SE

8.2.8. Celogics Inc

8.2.9. Catalent, Inc

8.2.10. CCRM

8.2.11. Applied StemCell Inc. (ASC)

8.2.12. Sartorius AG

8.2.13. Pluristyx Inc.

8.2.14. RoslinCT

8.2.15. Takara Bio Inc

8.2.16. Thermo Fisher Scientific, Inc

8.2.17. Other Prominent Players

Global iPSCs Manufacturing Services Market, by By Applications, 2022-2030 (Value US$ Mn)

  • Research Products
  • Drug Development & Discovery
  • Cellular Therapy
  • Toxicology Screening
  • Personalized Medicine
  • Disease Modelling
  • Stem Cell Banking
  • Emerging Applications

Global iPSCs Manufacturing Services Market, by End-user, 2022-2030 (Value US$ Mn)

  • Pharmaceutical & Biotechnology Companies
  • Academic institutes, Research Laboratories & CROs
  • Hospitals & Surgical Centres
  • Cell & Tissue Banks
  • Other End Users

Global iPSCs Manufacturing Services Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients